3Fukudo S, Nomur T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in irritable bowel syndrome [J]. Gut,1998;42(6) :845
4Bearcroft CD, Perrett D. Postprandial plasma 5-HT in diarrhoea predominant irritable bowel syndrome [ J ].Gut,1998;42 (1) :42
5Sanger GJ. 5-HT and functional bowel disorders [J].Neurogastroenterol Motil,1996;8(4) :319
6Maxton DC. Selective 5-HT antagonism: a role in irritable bowel syndrome and functional dyspepsia [ J ].Aliment Pharmacol Ther,1996 ;10(4) :595
7Gorazziari E. Role of opioid liands in the irritable bowel syndrome [J]. Can J Gastroenterol,1999;13(suppl A):71A
8Gamilleri M. Motor function in irritable bowel syndrome [J]. Can J Gastroenterol,1999;13(suppl A):8A
9Baldi F, Longanesi A, Blasi A, et al. Octylonium bromide in the treatment of the irritable bowel syndrome:a clinical-functional y. Hepatogastroenterology,1992 ;39:392
10Schutze K, Brandstatter G, Dragosics B, et al. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. Aliment Pharmacol Ther, 1997; 11:387
